Bausch Health Companies Inc.: all 534 studies
Page 6 of 6. Open to participants first (17), then studies with results posted, then the rest; newest registration first within each.
- Facial Lipoatrophy Correction Experience With SCULPTRA ("FACES" Study)CompletedNCT00360932
- A Study Comparing the Effectiveness and Safety of Extended Release Tramadol HCl at 100 mg, 200 mg and 300 mg Doses to Placebo for the Treatment of Moderate to Severe Pain Due to Osteoarthritis (OA)CompletedNCT00348452Phase 3
- Study to Evaluate Plasmin for the Creation of a Posterior Vitreous DetachmentTerminatedNCT00348439Phase 2
- A Study Comparing the Effectiveness and Safety of Extended Release Tramadol Versus Placebo for the Treatment of Osteoarthritis (OA) of the KneeCompletedNCT00348010Phase 3
- A Study to Evaluate the Safety and Effectiveness of the 217z Laser With Zyoptix for LasikWithdrawnNCT00347997Not applicable
- A Study Comparing the Effectiveness and Safety of Extended-release Tramadol Versus Placebo in the Treatment of Chronic Low Back PainCompletedNCT00347724Phase 3
- A One-year, Open-label Study to Assess the Safety and Effectiveness of Extended Release Tramadol HCl in the Treatment of Chronic, Non-malignant Pain.CompletedNCT00347685Phase 3
- A Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment (PVD)TerminatedNCT00347646Phase 1/2
- A Clinical Evaluation of the Next Generation Diagnostic Instrument (NGDI)CompletedNCT00347594Not applicable
- Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract SurgeryCompletedNCT00333918Phase 3
- Prevention of Travelers' Diarrhea in Subjects Traveling Outside the U.S.CompletedNCT00328380Phase 3
- A Study Comparing the Effectiveness and Safety of Varying Dose Strengths (100, 200, 300 and 400 mg) of Extended-release Tramadol HCl With Placebo for the Treatment of Osteoarthritis(OA) of the Knee and/or HipCompletedNCT00325858Phase 3
- Study Evaluating the Safety of MOA-728 Administered Orally to Healthy SubjectsCompletedNCT00311350Phase 1
- Viral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic Hepatitis CTerminatedNCT00305383Phase 2
- New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative ColitisCompletedNCT00269438Phase 3
- Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel SyndromeCompletedNCT00269412Phase 2
- Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment-NaiveCompletedNCT00230958Phase 3
- Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis BCompletedNCT00230503Phase 2
- Open-label Treatment Extension Study for Patients Who Complete Study RNA200103-201TerminatedNCT00230490Phase 2
- Evaluation of Vitrase as an Adjuvant to Increase Absorption and Dispersion of Other Injected AnestheticsCompletedNCT00198549Phase 4
- Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye SyndromeCompletedNCT00198536Phase 2/3
- A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForteCompletedNCT00198523Phase 3
- Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous HemorrhageCompletedNCT00198510Phase 3
- Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous HemorrhageCompletedNCT00198497Phase 3
- Evaluation of Vitrase as a Spreading AgentCompletedNCT00198484Phase 3
- Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous DetachmentCompletedNCT00198471Phase 2
- Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)CompletedNCT00198458Phase 1
- Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract SurgeryCompletedNCT00198445Phase 3
- Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)CompletedNCT00198419Phase 1
- Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined TherapyCompletedNCT00162734Phase 3
- A Study of Crofelemer to Treat Diarrhea Irritable Bowel SyndromeCompletedNCT00101725Phase 2
- Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment NaiveCompletedNCT00093093Phase 3
- Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined TherapyCompletedNCT00086541Phase 3
- Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically IllCompletedNCT00045799Phase 3